Improving Clinical Trial Awareness in NSCLC: Pilot Testing A Novel Healthcare IT Platform for Incorporating Education at the Point of Care



Status:Recruiting
Conditions:Lung Cancer, Lung Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:10/7/2018
Start Date:March 2015
Contact:Joshua Bauml, MD
Email:PennCancerTrials@emergingmed.com
Phone:855-216-0098

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
The objective of this study is to 1) evaluate the impact of a novel individualized care
planning/ educational technology (the On Q Care Planning System or CPS) on oncology patient
and provider knowledge, attitudes and beliefs about Non-Small Cell Lung Carcinoma (NSCLC)
clinical trials, as well as 2) to evaluate the impact of the On Q CPS on patient referral to
and enrollment in NSCLC clinical trials.


Inclusion Criteria:

- All participants must be 18 years of age or older.

- Patient participants must have Stage III, IV and/or recurrent NSCLC.

- Patient participants must be at a point of treatment initiation/change or evaluation
for treatment initiation/change

- Patients must have working email address and internet access

Exclusion Criteria:

- Any participant who cannot understand written or spoken English.

- Any participant who is not competent to provide informed consent for study
participation per the investigator.

- Any participant who cannot be present for the related study visits and/or complete the
post-test assessment
We found this trial at
1
site
Abramson Cancer Center of the University of Pennsylvania
3400 Civic Center Blvd
Philadelphia, Pennsylvania 19104
(215) 662-6065
Principal Investigator: Joshua Bauml, MD
Phone: 855-216-0098
Abramson Cancer Center of the University of Pennsylvania The Abramson Cancer Center of the University...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials